22nd Century Group to be Added to Russell 2000, Russell 3000, and Russell Global Indexes
June 13 2018 - 12:26PM
Business Wire
22nd Century Group, Inc. (NYSE American: XXII), a plant
biotechnology company that is a leader in tobacco harm reduction,
Very Low Nicotine tobacco, and hemp/cannabis research, announced
today that the Company will be added to the Russell 2000, Russell
3000, and Russell Global Indexes when FTSE Russell (Russell)
reconstitutes its U.S. and global equity indexes on June 22, 2018.
Russell’s preliminary announcement of its annual reconstitution of
these Indexes, which includes 22nd Century Group, was posted on the
Russell website on Friday, June 8, 2018, after the U.S. stock
market closed.
In 2017, Russell added 22nd Century to the Russell Microcap
index. With significant growth in the Company’s market
capitalization over the last year, 22nd Century has now earned its
placement on the more selective Russell Indexes. “22nd Century’s
increasing market value reflects the importance of our
extraordinary technology portfolio and the promise that our VLN™
tobacco represents in reducing the harm caused by smoking,”
explained Henry Sicignano, III, President and Chief Executive
Officer at 22nd Century Group. “What’s more, Russell’s inclusion of
22nd Century in its benchmark indexes will serve to generate
further interest in our Company among forward-looking
investors.”
Russell determines inclusion of companies in its equity indexes
by market-capitalization rankings and style attributes. Russell
indexes are widely used by investment managers and institutional
investors for index funds and as benchmarks for active investment
strategies. Approximately $8.6 trillion in assets are benchmarked
against Russell’s U.S. indexes.
About FTSE Russell
FTSE Russell is a leading global index provider creating and
managing a wide range of indexes, data and analytic solutions to
meet client needs across asset classes, style and strategies.
Covering 98% of the investable market, FTSE Russell indexes offer a
true picture of global markets, combined with the specialist
knowledge gained from developing local benchmarks around the
world.
FTSE Russell index expertise and products are used extensively
by institutional and retail investors around the world. More than
$10 trillion is currently benchmarked to FTSE Russell indexes. For
more than 30 years, leading asset owners, asset managers, ETF
providers and investment banks have chosen FTSE Russell indexes to
benchmark their investment performance and create investment funds,
ETFs, structured products and index-based derivatives. FTSE Russell
indexes also provide clients with tools for asset allocation,
investment strategy analysis and risk management.
FTSE Russell is wholly-owned by London Stock Exchange Group. For
more information, visit www.ftserussell.com
About 22nd Century Group, Inc.
22nd Century is a plant biotechnology company focused on
technology which allows it to increase or decrease the level of
nicotine in tobacco plants and the level of cannabinoids in
hemp/cannabis plants through genetic engineering and plant
breeding. The Company’s primary mission in tobacco is to reduce the
harm caused by smoking. The Company’s primary mission in
hemp/cannabis is to develop proprietary hemp strains for important
new medicines and agricultural crops. Visit www.xxiicentury.com and
www.botanicalgenetics.com for more information.
Cautionary Note Regarding Forward-Looking Statements: This press
release contains forward-looking information, including all
statements that are not statements of historical fact regarding the
intent, belief or current expectations of 22nd Century Group, Inc.,
its directors or its officers with respect to the contents of this
press release, including but not limited to our future revenue
expectations. The words “may,” “would,” “will,” “expect,”
“estimate,” “anticipate,” “believe,” “intend” and similar
expressions and variations thereof are intended to identify
forward-looking statements. We cannot guarantee future results,
levels of activity or performance. You should not place undue
reliance on these forward-looking statements, which speak only as
of the date that they were made. These cautionary statements should
be considered with any written or oral forward-looking statements
that we may issue in the future. Except as required by applicable
law, including the securities laws of the United States, we do not
intend to update any of the forward-looking statements to conform
these statements to reflect actual results, later events or
circumstances, or to reflect the occurrence of unanticipated
events. You should carefully review and consider the various
disclosures made by us in our annual report on Form 10-K for the
fiscal year ended December 31, 2017, filed on March 7, 2018,
including the section entitled “Risk Factors,” and our other
reports filed with the U.S. Securities and Exchange Commission
which attempt to advise interested parties of the risks and factors
that may affect our business, financial condition, results of
operation and cash flows. If one or more of these risks or
uncertainties materialize, or if the underlying assumptions prove
incorrect, our actual results may vary materially from those
expected or projected.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180613005921/en/
22nd Century GroupJames Vail, 716-270-1523Director of
Communicationsjvail@xxiicentury.com
22nd Century (AMEX:XXII)
Historical Stock Chart
From Aug 2024 to Sep 2024
22nd Century (AMEX:XXII)
Historical Stock Chart
From Sep 2023 to Sep 2024